Our Companies:

biocube ijuana biocell bioextracts nothern vines

Our Partners:

phyta experion ips

Learn About Abattis

intro

Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal and adult marijuana markets in North America.

Recent News

Stock Information

Abattis Bioceuticals Corp. (OTC: ATTBF)

Latest price $ 0.18 Volume 242437

(12-19-2014 20:25 EST)



Abattis Bioceuticals Corp. (CSE: ATT)

(Click here to view CSE quote)



Latest Videos

latest video

Email Updates

Quick Links

GDERS Model Learn More

Media Coverage Learn More